CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide.
We are currently looking for an Associate Director, Non-Clinical Pharmacology - CVR to join our team in Schlieren, Zurich.
Key Tasks
- Design and implement study protocols for nonclinical pharmacology studies with a particular focus on PK/PD and efficacy studies in translational models of disease in Cardiovascular and Renal indications
- Work closely with PK, Toxicology and Translational Science to integrate nonclinical pharmacology plans into a broader drug discovery plan to support effective project stage transitions and decision making
- Collaborate with internal teams, academic collaborators or CROs to ensure high-quality, timely execution of pharmacology studies and organizational alignment on key Go/No Go criteria
- Engage with and manage outside vendors and partners, including guidance and review of experiments conducted by third party vendors
- Participate in project teams and provide expert input on nonclinical pharmacology strategy and execution
- Prepare study reports, presentations, and present findings to internal stakeholders and external collaborators as needed
- Contribute to regulatory documents for IND submission
- Foster a culture of scientific excellence, psychological safety, innovation, and continuous growth
Your Profile
- Ph.D. in Pharmacology, Physiology, Biomedical Sciences, or a related field.
- 5+ years of experience in nonclinical pharmacology within the pharmaceutical or biotech industry with proven understanding of drug discovery and pharmaceutical development
- Expertise in in vivo pharmacology, disease models, and translational science for the relevant TA (Cardiovascular and/or Renal Disease Biology).
- Experience across multiple therapeutic areas and modalities is highly desirable Proven ability to work in project teams and to manage multiple projects and timelines
Are you interested? We are looking forward to receiving your online application.
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.